Levetiracetam recalls

The FDA has published 10 recalls involving Levetiracetam since 2012. The latest was reported on 7 Jun 2023. Most were for potency & assay. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls10since 2012

Last 12 months0reported

Class I110% of total

Ongoing1latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 10%Class II 7 70%Class III 2 20%

Why levetiracetam is recalled

Companies

Brands

Levetiracetam330%
Keppra110%

By year

2023110%
2021220%
2020220%
2019330%
2018110%
2012110%

Ongoing levetiracetam recalls

1 active

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Levetiracetam Oral Solution 100 mg/mL (100 mg/mL) recalled by Akorn	Akorn	Potency & Assay	Nationwide

All levetiracetam recalls, newest first

10 total

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Levetiracetam Oral Solution 100 mg/mL (100 mg/mL) recalled by Akorn	Akorn	Potency & Assay	Nationwide
16 Jun 2021Drug	CLASS III	Levetiracetam Tablets USP, 250 mg UD recalled by McKesson	McKesson	Other	Nationwide
20 Jan 2021Drug	CLASS II	Levetiracetam Oral Solution, 100 mg/mL recalled by Akorn	Akorn	Packaging Defects	Nationwide
2 Dec 2020Drug	CLASS II	Levetiracetam Tablets, USP 500 mg recalled by Eywa Pharma	Eywa Pharma	Packaging Defects	Nationwide
22 Apr 2020Drug	CLASS II	Levetiracetam Tablets USP 750 mg recalled by Aurobindo Pharma USALevetiracetam	Aurobindo Pharma USA	Manufacturing (CGMP) Deviations	Nationwide
25 Dec 2019Drug	CLASS I	Levetiracetam Oral Solution 100mg/mL recalled by Lannett Company	Lannett Company	Sterility	Nationwide
27 Nov 2019Drug	CLASS III	Levetiracetam Injection, 500 mg/-use vials recalledLevetiracetam	X-Gen Pharmaceuticals	Packaging Defects	Nationwide
31 Jul 2019Drug	CLASS II	Keppra (levetiracetam) recalled by UcbKeppra	Ucb	Potency & Assay	TN
28 Feb 2018Drug	CLASS II	Levetiracetam USP for prescription compounding recalled	American Pharmaceutical Ingredients	Potency & Assay	Nationwide
3 Oct 2012Drug	CLASS II	Levetiracetam Tablets, USP 500 mg recalled by Mylan PharmaceuticalsLevetiracetam	Mylan Pharmaceuticals	Other	KY

Should you stop taking Levetiracetam?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.